应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BMY 施贵宝
已收盘 07-02 16:00:00 EDT
40.45
-0.85
-2.06%
盘后
40.40
-0.05
-0.12%
19:59 EDT
最高
41.35
最低
40.41
成交量
1,828万
今开
41.26
昨收
41.30
日振幅
2.28%
总市值
819.96亿
流通市值
818.39亿
总股本
20.27亿
成交额
7.42亿
换手率
0.90%
流通股本
20.23亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
百时美施贵宝下跌1.28%,报40.77美元/股
金融界 · 07-02 21:59
百时美施贵宝下跌1.28%,报40.77美元/股
31亿美元BD之死
蓝鲸财经 · 07-02 11:58
31亿美元BD之死
百时美施贵宝下跌1.32%,报41.94美元/股
金融界 · 06-27
百时美施贵宝下跌1.32%,报41.94美元/股
百时美施贵宝下跌1.23%,报41.71美元/股
金融界 · 06-25
百时美施贵宝下跌1.23%,报41.71美元/股
美国 FDA 批准百时美施贵宝公司的结直肠癌疗法
Reuters · 06-22
美国 FDA 批准百时美施贵宝公司的结直肠癌疗法
百时美施贵宝上涨1.41%,报41.62美元/股
金融界网站 · 06-21
百时美施贵宝上涨1.41%,报41.62美元/股
百时美施贵宝:FDA授于瑞普替尼)“加速审批”资格
金融界 · 06-14
百时美施贵宝:FDA授于瑞普替尼)“加速审批”资格
百时美施贵宝下跌1.3%,报41.86美元/股
金融界 · 06-13
百时美施贵宝下跌1.3%,报41.86美元/股
百时美施贵宝下跌1.29%,报42.02美元/股
金融界 · 06-11
百时美施贵宝下跌1.29%,报42.02美元/股
百时美施贵宝上涨1.31%,报42.025美元/股
金融界 · 06-10
百时美施贵宝上涨1.31%,报42.025美元/股
BUZZ-血液病药物首次获得 FDA 批准,杰龙业绩大增
Reuters · 06-08
BUZZ-血液病药物首次获得 FDA 批准,杰龙业绩大增
百时美施贵宝上涨1.23%,报41.383美元/股
金融界 · 06-07
百时美施贵宝上涨1.23%,报41.383美元/股
健康巡讲:未经治疗的心房颤动会增加痴呆症和死亡的风险
Reuters · 06-07
健康巡讲:未经治疗的心房颤动会增加痴呆症和死亡的风险
百时美施贵宝上涨3.03%,报42.335美元/股
金融界 · 06-03
百时美施贵宝上涨3.03%,报42.335美元/股
使用百时美施贵宝联合疗法进行手术前治疗可提高皮肤癌治疗效果
Reuters · 06-02
使用百时美施贵宝联合疗法进行手术前治疗可提高皮肤癌治疗效果
百时美施贵宝上涨1.22%,报40.74美元/股
金融界 · 05-31
百时美施贵宝上涨1.22%,报40.74美元/股
诺华白血病药物在试验中比旧版疗法更有效
Reuters · 05-31
诺华白血病药物在试验中比旧版疗法更有效
百时美施贵宝(BMY)CAR-T疗法获美FDA批准
金吾财讯 · 05-31
百时美施贵宝(BMY)CAR-T疗法获美FDA批准
百时美施贵宝(中国)投资有限公司申请III类会议
金融界 · 05-31
百时美施贵宝(中国)投资有限公司申请III类会议
百时美施贵宝表示其癌细胞疗法Breyanzi的批发标价为487,477.43美元——声明
智通财经 · 05-31
百时美施贵宝表示其癌细胞疗法Breyanzi的批发标价为487,477.43美元——声明
加载更多
公司概况
公司名称:
施贵宝
所属市场:
NYSE
上市日期:
--
主营业务:
百时美施贵宝公司于1933年8月根据特拉华州法律注册成立,名为百时美公司,继承了1887年在纽约成立的一家企业。1989年,由于合并,公司更名为百时美施贵宝公司。公司在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。他们在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。 他们预计他们对Celgene和MyoKardia的收购将进一步将他们定位为领先的生物制药公司,通过多项近期资产和额外的外部合作伙伴扩大他们的肿瘤学、血液学、免疫学和心血管产品组合。
发行价格:
--
{"stockData":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"施贵宝","latestPrice":40.45,"timestamp":1719950400000,"preClose":41.3,"halted":0,"volume":18280232,"hourTrading":{"tag":"盘后","latestPrice":40.4,"preClose":40.45,"latestTime":"19:59 EDT","volume":4618140,"amount":186798405.1237,"timestamp":1719964742870},"delay":0,"floatShares":2023216780,"shares":2027100096,"eps":-3.002585,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.85,"latestTime":"07-02 16:00:00 EDT","open":41.26,"high":41.35,"low":40.41,"amount":742352543.8225601,"amplitude":0.02276,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.002585,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1719993600000},"adr":0,"listingDate":-18475200000,"adjPreClose":41.3,"adrRate":0,"dividendRate":0.057849,"preHourTrading":{"tag":"盘前","latestPrice":41.406,"preClose":41.3,"latestTime":"09:29 EDT","volume":12860,"amount":531902.8458,"timestamp":1719926970291},"postHourTrading":{"tag":"盘后","latestPrice":40.4,"preClose":40.45,"latestTime":"19:59 EDT","volume":4618140,"amount":186798405.1237,"timestamp":1719964742870},"volumeRatio":0.991579,"impliedVol":0.3062,"impliedVolPercentile":0.877},"requestUrl":"/m/hq/s/BMY","defaultTab":"news","newsList":[{"id":"2448157276","title":"百时美施贵宝下跌1.28%,报40.77美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448157276","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448157276?lang=zh_cn&edition=full","pubTime":"2024-07-02 21:59","pubTimestamp":1719928772,"startTime":"0","endTime":"0","summary":"7月2日,百时美施贵宝(BMY)盘中下跌1.28%,截至21:59,报40.77美元/股,成交4085.7万美元。财务数据显示,截至2024年03月31日,百时美施贵宝收入总额118.65亿美元,同比增长4.66%;归母净利润-119.11亿美元,同比减少626.57%。大事提醒:7月26日,百时美施贵宝将于(美东)盘前披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/02215941335461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1670711040.USD","IE00BSNM7G36.USD","LU0868494617.USD","IE00B2B36J28.USD","LU2242646821.SGD","LU0321505868.SGD","LU2133065610.SGD","BK4532","LU1670711123.USD","LU2242652126.USD","LU0114720955.EUR","LU1670710588.SGD","LU0237698245.USD","IE00BJJMRZ35.SGD","LU1718418525.SGD","LU2125154778.USD","LU0456855351.SGD","LU0321505439.SGD","LU2360032135.SGD","LU1074936037.SGD","LU0061475181.USD","BK4581","LU1571399168.USD","BK4534","LU2125154935.USD","LU1989771016.USD","BK4585","BK4007","BMY","LU0882574055.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU1261432733.SGD","LU1430594728.SGD","LU1585245621.USD","LU1291159041.SGD","BK4588","IE0009355771.USD","BK4559","LU1032466523.USD","LU1670710661.SGD","IE0002141913.USD"],"gpt_icon":0},{"id":"2448905431","title":"31亿美元BD之死","url":"https://stock-news.laohu8.com/highlight/detail?id=2448905431","media":"蓝鲸财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448905431?lang=zh_cn&edition=full","pubTime":"2024-07-02 11:58","pubTimestamp":1719892710,"startTime":"0","endTime":"0","summary":"自2022年下半年以来,FRα ADC领域的好消息,接踵而至。Elahere上市,也意味着FRα作为药物靶点的有效性得到了证实。紧随其后,Immunogen公司超出预期的财务报告进一步提升了市场对FRα ADC的期待值,销量增长极大地推动了Immunogen公司的股价,并最终促成了其被艾伯维以超过100亿美元的价格收购。2024年7月1日,卫材公司宣布,其FRα ADC药物MORAb-202被百时美施贵宝退回,此前双方达成的价值31亿美元的BD合作,突然终止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/234417","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0321505868.SGD","LU0114720955.EUR","LU0321505439.SGD","LU1989771016.USD","LU0868494617.USD","LU2242646821.SGD","IE00BFTCPJ56.SGD","LU1670711123.USD","LU1430594728.SGD","LU1571399168.USD","LU1032466523.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0061475181.USD","LU1291159041.SGD","LU1718418525.SGD","BK4559","LU1670710588.SGD","BK4007","LU2133065610.SGD","LU2242652126.USD","BK4532","LU2125154778.USD","IE00BSNM7G36.USD","LU1670711040.USD","IE0002141913.USD","LU0237698245.USD","BK4581","IE00B2B36J28.USD","BK4585","BMY","LU1261432733.SGD","LU1074936037.SGD","LU1585245621.USD","LU2125154935.USD","LU0456855351.SGD","LU0882574055.USD","BK4588","BK4534","LU2360032135.SGD","LU1670710661.SGD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2446556506","title":"百时美施贵宝下跌1.32%,报41.94美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446556506","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446556506?lang=zh_cn&edition=full","pubTime":"2024-06-27 22:14","pubTimestamp":1719497690,"startTime":"0","endTime":"0","summary":"6月27日,百时美施贵宝(BMY)盘中下跌1.32%,截至22:14,报41.94美元/股,成交1.04亿美元。财务数据显示,截至2024年03月31日,百时美施贵宝收入总额118.65亿美元,同比增长4.66%;归母净利润-119.11亿美元,同比减少626.57%。大事提醒:7月26日,百时美施贵宝将于(美东)盘前披露2024财年中报。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062722182395de943b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062722182395de943b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJJMRZ35.SGD","LU0321505439.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","LU2242652126.USD","LU1718418525.SGD","IE0002141913.USD","LU1989771016.USD","BK4588","BK4581","LU2125154935.USD","LU2360032135.SGD","IE00B2B36J28.USD","IE00BSNM7G36.USD","LU0321505868.SGD","BK4007","LU1571399168.USD","LU1032466523.USD","LU1430594728.SGD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU0882574055.USD","LU1585245621.USD","LU1670710588.SGD","LU1670710661.SGD","LU1670711123.USD","BK4532","LU0114720955.EUR","LU1670711040.USD","LU1291159041.SGD","BK4534","LU1261432733.SGD","BMY","LU2125154778.USD","BK4585","BK4559","LU0456855351.SGD","LU1074936037.SGD","LU0237698245.USD","LU2133065610.SGD","LU2242646821.SGD","LU0061475181.USD"],"gpt_icon":0},{"id":"2446849070","title":"百时美施贵宝下跌1.23%,报41.71美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446849070","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446849070?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:41","pubTimestamp":1719322903,"startTime":"0","endTime":"0","summary":"6月25日,百时美施贵宝(BMY)盘中下跌1.23%,截至21:41,报41.71美元/股,成交2552.66万美元。财务数据显示,截至2024年03月31日,百时美施贵宝收入总额118.65亿美元,同比增长4.66%;归母净利润-119.11亿美元,同比减少626.57%。大事提醒:7月26日,百时美施贵宝将于(美东)盘前披露2024财年中报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/06/25214141190507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["IE0002141913.USD","LU1670711040.USD","IE00B2B36J28.USD","LU1670711123.USD","LU1585245621.USD","LU2242652126.USD","BK4559","LU0321505868.SGD","LU1989771016.USD","IE0009355771.USD","LU2125154778.USD","LU1670710661.SGD","LU1291159041.SGD","BK4534","BK4588","LU0882574055.USD","LU1032466523.USD","LU2242646821.SGD","LU1718418525.SGD","LU2133065610.SGD","BK4585","LU0868494617.USD","IE00BJT1NW94.SGD","LU1670710588.SGD","BK4007","LU0456855351.SGD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU0321505439.SGD","LU2360032135.SGD","LU1571399168.USD","LU0237698245.USD","LU0061475181.USD","LU1261432733.SGD","LU0114720955.EUR","BMY","BK4581","LU1074936037.SGD","BK4532","IE00BJJMRZ35.SGD","LU1430594728.SGD","LU2125154935.USD"],"gpt_icon":0},{"id":"2445360798","title":"美国 FDA 批准百时美施贵宝公司的结直肠癌疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2445360798","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445360798?lang=zh_cn&edition=full","pubTime":"2024-06-22 01:27","pubTimestamp":1718990876,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透6月21日 - 美国食品和药物管理局网站周五显示,该局已批准百时美施贵宝公司的 联合疗法用于治疗有特定基因突变的结直肠癌患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE0002141913.USD","LU2125154935.USD","BK4581","LU1032466523.USD","LU0061475181.USD","LU2242652126.USD","LU1989771016.USD","IE00BFTCPJ56.SGD","LU0114720955.EUR","IE00BSNM7G36.USD","LU1670710661.SGD","LU0321505868.SGD","IE00BJJMRZ35.SGD","LU1670711040.USD","BK4559","LU1261432733.SGD","LU0456855351.SGD","LU1571399168.USD","LU1718418525.SGD","LU1670711123.USD","LU0868494617.USD","IE00BJT1NW94.SGD","LU0882574055.USD","BK4532","LU2133065610.SGD","IE0009355771.USD","LU1291159041.SGD","BK4588","LU1585245621.USD","BK4007","LU2125154778.USD","BMY","IE00B2B36J28.USD","LU0321505439.SGD","LU2242646821.SGD","LU0237698245.USD","LU1670710588.SGD","LU2360032135.SGD","LU1074936037.SGD","BK4534","LU1430594728.SGD"],"gpt_icon":0},{"id":"2445768360","title":"百时美施贵宝上涨1.41%,报41.62美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445768360","media":"金融界网站","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445768360?lang=zh_cn&edition=full","pubTime":"2024-06-21 21:50","pubTimestamp":1718977800,"startTime":"0","endTime":"0","summary":"转自:金融界本文源自:金融界6月21日,百时美施贵宝(BMY)盘中上涨1.41%,截至21:43,报41.62美元/股,成交6926.55万美元。财务数据显示,截至2024年03月31日,百时美施贵宝收入总额118.65亿美元,同比增长4.66%;归母净利润-119.11亿美元,同比减少626.57%。大事提醒:6月18日,百时美施贵宝2023季度分配每1股派0.6美元股息,除权除息日2024-07-05,派息日2024-08-01。7月26日,百时美施贵宝将于(美东)盘前披露2024财年中报。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/bxjj/2024-06-21/doc-inazpixz3301171.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-06-21/doc-inazpixz3301171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0321505868.SGD","LU0114720955.EUR","LU0321505439.SGD","LU1989771016.USD","LU0868494617.USD","LU2242646821.SGD","IE00BFTCPJ56.SGD","LU1670711123.USD","LU1430594728.SGD","LU1571399168.USD","LU1032466523.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0061475181.USD","LU1291159041.SGD","LU1718418525.SGD","BK4559","LU1670710588.SGD","BK4007","LU2133065610.SGD","LU2242652126.USD","BK4532","LU2125154778.USD","IE00BSNM7G36.USD","LU1670711040.USD","IE0002141913.USD","LU0237698245.USD","BK4581","IE00B2B36J28.USD","BK4585","BMY","LU1261432733.SGD","LU1074936037.SGD","LU1585245621.USD","LU2125154935.USD","LU0456855351.SGD","LU0882574055.USD","BK4588","BK4534","LU2360032135.SGD","LU1670710661.SGD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2443228658","title":"百时美施贵宝:FDA授于瑞普替尼)“加速审批”资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2443228658","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443228658?lang=zh_cn&edition=full","pubTime":"2024-06-14 03:45","pubTimestamp":1718307924,"startTime":"0","endTime":"0","summary":"百时美施贵宝表示,美国食品药品管理局(FDA)授于repotrectinib(瑞普替尼,Augtyro)“加速审批”资格。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406140345309f3a023d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406140345309f3a023d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456855351.SGD","IE00BSNM7G36.USD","LU0882574055.USD","LU2125154778.USD","LU0321505868.SGD","LU0237698245.USD","BK4585","LU1032466523.USD","IE0002141913.USD","BK4532","IE00BFTCPJ56.SGD","LU2242652126.USD","BK4588","LU0321505439.SGD","LU1989771016.USD","LU1291159041.SGD","BK4581","LU1670711123.USD","LU1670711040.USD","BMY","IE00BJT1NW94.SGD","LU2125154935.USD","LU1430594728.SGD","LU1670710588.SGD","BK4007","IE00B2B36J28.USD","LU1074936037.SGD","LU1585245621.USD","LU0868494617.USD","LU1261432733.SGD","LU1571399168.USD","BK4534","LU2360032135.SGD","LU2242646821.SGD","LU0061475181.USD","LU2133065610.SGD","IE0009355771.USD","BK4559","LU1670710661.SGD","IE00BJJMRZ35.SGD","LU0114720955.EUR","LU1718418525.SGD"],"gpt_icon":0},{"id":"2443689452","title":"百时美施贵宝下跌1.3%,报41.86美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2443689452","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443689452?lang=zh_cn&edition=full","pubTime":"2024-06-13 21:45","pubTimestamp":1718286359,"startTime":"0","endTime":"0","summary":"6月13日,百时美施贵宝(BMY)盘中下跌1.3%,截至21:45,报41.86美元/股,成交3424.94万美元。财务数据显示,截至2024年03月31日,百时美施贵宝收入总额118.65亿美元,同比增长4.66%;归母净利润-119.11亿美元,同比减少626.57%。大事提醒:7月26日,百时美施贵宝将于(美东)盘前披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/06/13214541011916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1670711040.USD","LU1074936037.SGD","LU2133065610.SGD","LU1291159041.SGD","IE0002141913.USD","IE00BJT1NW94.SGD","LU2242652126.USD","LU1718418525.SGD","LU1032466523.USD","LU0114720955.EUR","LU0237698245.USD","LU1261432733.SGD","LU0882574055.USD","LU1571399168.USD","BK4588","IE00BJJMRZ35.SGD","BMY","LU1430594728.SGD","LU1585245621.USD","LU2125154778.USD","IE00B2B36J28.USD","BK4534","LU2242646821.SGD","LU1989771016.USD","BK4581","BK4532","LU1670710588.SGD","LU0061475181.USD","LU0321505868.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU0868494617.USD","LU1670711123.USD","LU2125154935.USD","IE00BSNM7G36.USD","BK4559","LU0321505439.SGD","LU2360032135.SGD","LU0456855351.SGD","LU1670710661.SGD","BK4585","BK4007"],"gpt_icon":0},{"id":"2442392660","title":"百时美施贵宝下跌1.29%,报42.02美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2442392660","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442392660?lang=zh_cn&edition=full","pubTime":"2024-06-11 22:03","pubTimestamp":1718114622,"startTime":"0","endTime":"0","summary":"6月11日,百时美施贵宝(BMY)盘中下跌1.29%,截至22:03,报42.02美元/股,成交3818.3万美元。财务数据显示,截至2024年03月31日,百时美施贵宝收入总额118.65亿美元,同比增长4.66%;归母净利润-119.11亿美元,同比减少626.57%。大事提醒:7月26日,百时美施贵宝将于(美东)盘前披露2024财年中报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/06/11220340980332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BMY","LU1670711123.USD","LU1670711040.USD","BK4532","LU0321505439.SGD","LU0882574055.USD","BK4585","LU0868494617.USD","LU1032466523.USD","LU1670710661.SGD","IE00B2B36J28.USD","LU0237698245.USD","BK4588","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU1585245621.USD","IE0002141913.USD","LU2242652126.USD","LU0114720955.EUR","LU2125154778.USD","LU1718418525.SGD","LU0061475181.USD","LU1670710588.SGD","BK4007","LU1571399168.USD","IE00BSNM7G36.USD","LU1261432733.SGD","LU1989771016.USD","IE00BJT1NW94.SGD","LU2242646821.SGD","BK4581","LU1430594728.SGD","LU1074936037.SGD","LU2360032135.SGD","LU0321505868.SGD","LU1291159041.SGD","LU0456855351.SGD","LU2133065610.SGD","BK4534","BK4559","LU2125154935.USD"],"gpt_icon":0},{"id":"2442584789","title":"百时美施贵宝上涨1.31%,报42.025美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2442584789","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442584789?lang=zh_cn&edition=full","pubTime":"2024-06-10 22:01","pubTimestamp":1718028108,"startTime":"0","endTime":"0","summary":"6月10日,百时美施贵宝(BMY)盘中上涨1.31%,截至22:01,报42.025美元/股,成交4478.81万美元。财务数据显示,截至2024年03月31日,百时美施贵宝收入总额118.65亿美元,同比增长4.66%;归母净利润-119.11亿美元,同比减少626.57%。大事提醒:7月26日,百时美施贵宝将于(美东)盘前披露2024财年中报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/06/10220140966579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0456855351.SGD","LU0321505439.SGD","LU1074936037.SGD","BMY","LU1989771016.USD","LU2125154778.USD","LU2242646821.SGD","LU1670711040.USD","LU1670710661.SGD","LU1032466523.USD","BK4588","BK4532","BK4585","IE00BJJMRZ35.SGD","BK4559","IE00B2B36J28.USD","BK4581","LU1430594728.SGD","LU0237698245.USD","LU1670710588.SGD","LU1718418525.SGD","BK4007","LU0868494617.USD","LU0061475181.USD","LU2242652126.USD","BK4534","LU2360032135.SGD","LU1291159041.SGD","IE00BSNM7G36.USD","LU0321505868.SGD","LU2133065610.SGD","LU1571399168.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0882574055.USD","LU1261432733.SGD","IE0009355771.USD","LU1585245621.USD","LU2125154935.USD","LU1670711123.USD","IE0002141913.USD","LU0114720955.EUR"],"gpt_icon":0},{"id":"2441814093","title":"BUZZ-血液病药物首次获得 FDA 批准,杰龙业绩大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2441814093","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441814093?lang=zh_cn&edition=full","pubTime":"2024-06-08 00:04","pubTimestamp":1717776246,"startTime":"0","endTime":"0","summary":"** 该药将以 Rytelo 品牌销售,188 毫克小瓶的批发价为 9884 美元,47 毫克小瓶的批发价为 2471 美元。* * 该药将与百时美施贵宝公司的 Reblozyl竞争,后者 去年 获得了该机构 的扩大批准 ,用于治疗相同的疾病适应症。** Baird 券商预计,2029 年 Rytelo 的销售额将达到 9.33 亿美元,而 B. Riley Securities 则认为最高销售额将达到 7 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4559","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4585","BK4007","LU0456855351.SGD","LU2242646821.SGD","LU0061475181.USD","LU0868494617.USD","IE00B2B36J28.USD","LU1670711123.USD","BK4588","LU2125154778.USD","LU1718418525.SGD","LU1430594728.SGD","LU2133065610.SGD","LU1670711040.USD","GERN","LU1670710588.SGD","LU2242652126.USD","BK4532","LU2360032135.SGD","LU1032466523.USD","LU0882574055.USD","LU1585245621.USD","LU1670710661.SGD","IE0002141913.USD","LU1074936037.SGD","LU1571399168.USD","BUZZ","LU0237698245.USD","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","LU0114720955.EUR","BMY","IE0009355771.USD","LU0321505868.SGD","BK4581","LU1291159041.SGD","LU2125154935.USD","LU0321505439.SGD","LU1261432733.SGD","BK4139","LU1989771016.USD"],"gpt_icon":0},{"id":"2441606467","title":"百时美施贵宝上涨1.23%,报41.383美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2441606467","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441606467?lang=zh_cn&edition=full","pubTime":"2024-06-07 22:14","pubTimestamp":1717769664,"startTime":"0","endTime":"0","summary":"6月7日,百时美施贵宝(BMY)盘中上涨1.23%,截至22:14,报41.383美元/股,成交6506.51万美元。财务数据显示,截至2024年03月31日,百时美施贵宝收入总额118.65亿美元,同比增长4.66%;归母净利润-119.11亿美元,同比减少626.57%。大事提醒:7月26日,百时美施贵宝将于(美东)盘前披露2024财年中报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/06/07221440956414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1261432733.SGD","BK4588","LU0321505439.SGD","LU1670711123.USD","LU2360032135.SGD","LU0882574055.USD","LU1989771016.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","BK4585","LU0321505868.SGD","LU1430594728.SGD","LU1585245621.USD","LU2125154935.USD","LU0237698245.USD","LU1718418525.SGD","LU1032466523.USD","BK4581","BK4534","LU1074936037.SGD","LU2125154778.USD","LU0114720955.EUR","BK4007","LU0061475181.USD","BMY","LU0456855351.SGD","BK4559","LU1291159041.SGD","BK4532","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU1670710661.SGD","LU1670711040.USD","LU2242646821.SGD","LU0868494617.USD","IE00BSNM7G36.USD","LU2133065610.SGD","LU1571399168.USD","LU1670710588.SGD","LU2242652126.USD","IE0009355771.USD"],"gpt_icon":0},{"id":"2441291397","title":"健康巡讲:未经治疗的心房颤动会增加痴呆症和死亡的风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2441291397","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441291397?lang=zh_cn&edition=full","pubTime":"2024-06-07 03:26","pubTimestamp":1717701981,"startTime":"0","endTime":"0","summary":"未经治疗的心律失常与痴呆症的高风险有关英国一项大型研究显示,患有常见心律失常的心房颤动患者如果不服用可降低中风风险的血液稀释剂,患痴呆症和死亡的风险也会更高。这组患者在研究期间的死亡风险也高出44%,患血管性痴呆的风险高出68%。研究人员指出,这项研究并不是为了证明未经治疗的阿非布会导致这些结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU0456855351.SGD","LU1032466523.USD","LU0912757837.SGD","SG9999001440.SGD","LU2133065610.SGD","LU0640476718.USD","LU0170899867.USD","BK4585","LU0795875086.SGD","LU2360032135.SGD","LU2242646821.SGD","SG9999002232.USD","BK4588","LU1244550494.USD","LU1670711040.USD","BK4592","IE00B2B36J28.USD","LU0321505439.SGD","LU1059921491.USD","LU1585245621.USD","LU1430594728.SGD","IE00BSNM7G36.USD","LU0234572021.USD","LU1221951046.USD","LU1718418525.SGD","LU1032955483.USD","SG9999002224.SGD","LU2347655156.SGD","LU1291159041.SGD","LU0889566641.SGD","LU1732800096.USD","LU2602419157.SGD","PFE","BK4559","SG9999013999.USD","LU0289739699.SGD","LU1244550577.SGD","JNJ","BMY","IE00BLSP4239.USD","LU1221951129.SGD","LU2125154935.USD","LU1023059063.AUD","BK4568","LU2125154778.USD","IBD","LU1196500208.SGD","IE00BLSP4452.SGD","LU1267930813.SGD"],"gpt_icon":0},{"id":"2440491213","title":"百时美施贵宝上涨3.03%,报42.335美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2440491213","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440491213?lang=zh_cn&edition=full","pubTime":"2024-06-03 22:39","pubTimestamp":1717425560,"startTime":"0","endTime":"0","summary":"6月3日,百时美施贵宝(BMY)盘中上涨3.03%,截至22:39,报42.335美元/股,成交1.38亿美元。财务数据显示,截至2024年03月31日,百时美施贵宝收入总额118.65亿美元,同比增长4.66%;归母净利润-119.11亿美元,同比减少626.57%。大事提醒:7月25日,百时美施贵宝将披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/06/03223940880178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["IE00BJJMRZ35.SGD","LU0321505439.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","LU2242652126.USD","LU1718418525.SGD","IE0002141913.USD","LU1989771016.USD","BK4588","BK4581","LU2125154935.USD","LU2360032135.SGD","IE00B2B36J28.USD","IE00BSNM7G36.USD","LU0321505868.SGD","BK4007","LU1571399168.USD","LU1032466523.USD","LU1430594728.SGD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU0882574055.USD","LU1585245621.USD","LU1670710588.SGD","LU1670710661.SGD","LU1670711123.USD","BK4532","LU0114720955.EUR","LU1670711040.USD","LU1291159041.SGD","BK4534","LU1261432733.SGD","BMY","LU2125154778.USD","BK4585","BK4559","LU0456855351.SGD","LU1074936037.SGD","LU0237698245.USD","LU2133065610.SGD","LU2242646821.SGD","LU0061475181.USD"],"gpt_icon":0},{"id":"2440014046","title":"使用百时美施贵宝联合疗法进行手术前治疗可提高皮肤癌治疗效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2440014046","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440014046?lang=zh_cn&edition=full","pubTime":"2024-06-02 20:00","pubTimestamp":1717329616,"startTime":"0","endTime":"0","summary":"研究人员在芝加哥举行的美国临床肿瘤学会 会议上报告说,没有接受所谓的新辅助治疗但在术后一年接受 Opdivo 治疗的患者的 12 个月无事件生存率为 57.2%。这项研究由荷兰癌症研究所和澳大利亚黑色素瘤研究所赞助,并得到了百时美施贵宝公司和澳大利亚国家健康与医学研究委员会的资助。","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1670711040.USD","LU2133065610.SGD","LU1670710588.SGD","BK4581","BK4007","IE00BJJMRZ35.SGD","IE0002141913.USD","LU0237698245.USD","LU1430594728.SGD","BK4585","LU0061475181.USD","LU1670710661.SGD","LU0456855351.SGD","LU1989771016.USD","LU1571399168.USD","LU1585245621.USD","LU1718418525.SGD","BMY","IE00B2B36J28.USD","LU0321505868.SGD","IE00BJT1NW94.SGD","LU0321505439.SGD","BK4559","LU1261432733.SGD","LU1670711123.USD","LU0114720955.EUR","LU1291159041.SGD","BK4534","IE0009355771.USD","BK4532","LU2242646821.SGD","LU2242652126.USD","LU1074936037.SGD","BK4588","LU0868494617.USD","LU2125154778.USD","LU2360032135.SGD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU1032466523.USD","LU2125154935.USD","LU0882574055.USD"],"gpt_icon":0},{"id":"2439191806","title":"百时美施贵宝上涨1.22%,报40.74美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2439191806","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439191806?lang=zh_cn&edition=full","pubTime":"2024-05-31 22:23","pubTimestamp":1717165433,"startTime":"0","endTime":"0","summary":"5月31日,百时美施贵宝(BMY)盘中上涨1.22%,截至22:23,报40.74美元/股,成交7902.67万美元。财务数据显示,截至2024年03月31日,百时美施贵宝收入总额118.65亿美元,同比增长4.66%;归母净利润-119.11亿美元,同比减少626.57%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/31222340855246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1571399168.USD","LU0061475181.USD","BK4532","IE00BSNM7G36.USD","LU1261432733.SGD","LU1670710661.SGD","LU1585245621.USD","BK4534","BK4588","LU2133065610.SGD","LU2360032135.SGD","BK4007","IE00BJT1NW94.SGD","LU1291159041.SGD","LU1670710588.SGD","LU1430594728.SGD","BK4585","LU1032466523.USD","IE00B2B36J28.USD","BK4581","LU0321505439.SGD","IE0009355771.USD","LU0456855351.SGD","LU0882574055.USD","LU1718418525.SGD","LU0237698245.USD","LU0114720955.EUR","LU1670711040.USD","LU1989771016.USD","BMY","LU2242652126.USD","LU1074936037.SGD","LU0321505868.SGD","LU2242646821.SGD","LU2125154778.USD","IE00BJJMRZ35.SGD","LU2125154935.USD","LU0868494617.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4559","LU1670711123.USD"],"gpt_icon":0},{"id":"2439998792","title":"诺华白血病药物在试验中比旧版疗法更有效","url":"https://stock-news.laohu8.com/highlight/detail?id=2439998792","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439998792?lang=zh_cn&edition=full","pubTime":"2024-05-31 20:00","pubTimestamp":1717156804,"startTime":"0","endTime":"0","summary":"虽然旧的TKIs彻底改变了CML的治疗,但许多患者最终症状复发或因副作用而无法继续治疗。在试验期间,仅有5%的Scemblix患者因不良副作用而中断治疗,而接受任何一种TKIs治疗的患者的辍治率为10%,TKIs可导致疲劳、抑郁、睡眠紊乱、腹泻和其他副作用。该试验仍在进行中,下一次计划在第96周进行分析,以进一步评估MMR和停药率。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","LU1023059063.AUD","LU0321505868.SGD","SG9999003800.SGD","LU1066053197.SGD","LU0211331839.USD","BK4532","LU1670711123.USD","BK4533","LU2242652126.USD","LU0114720955.EUR","LU1670710588.SGD","SGXZ57979304.SGD","LU0237698245.USD","IE0002270589.USD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU0321505439.SGD","LU1074936037.SGD","PFE","LU1057294990.SGD","SG9999001176.USD","LU0061475181.USD","LU1571399168.USD","BK4534","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU1989771016.USD","BK4585","BK4007","SG9999011175.SGD","NVS","BMY","LU0882574055.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","BK4550","LU0289739699.SGD","LU0122379950.USD","BK4568","SG9999001176.SGD","LU1261432733.SGD","LU1585245621.USD","IE00BLSP4239.USD","LU1066051498.USD","LU0170899867.USD","IE0009355771.USD","BK4559","LU1670710661.SGD","IE0002141913.USD"],"gpt_icon":0},{"id":"2439984305","title":"百时美施贵宝(BMY)CAR-T疗法获美FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2439984305","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439984305?lang=zh_cn&edition=full","pubTime":"2024-05-31 09:29","pubTimestamp":1717118972,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据悉,百时美施贵宝(BMY)于当地时间5月30日宣布,美国食品药品管理局(FDA)已批准其CAR-T疗法Breyanzi(lisocabtagene maraleucel;liso-cel)的扩展适应症,用于既往接受过至少2线系统性疗法的复发性或难治性套细胞淋巴瘤(MCL)成人患者,包括曾接受过布鲁顿酪氨酸激酶(BTK)抑制剂治疗的患者。新闻稿称,Breyanzi是目前唯一获美国FDA批准用于治疗四种不同亚型非霍奇金淋巴瘤的CAR-T疗法,使之能够治疗B细胞恶性肿瘤患者。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/YmVhNzU1OTk0YzMzOThlZmE0ZWZmYWYzMTBiMjQwNzE0NzYxMTczOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/YmVhNzU1OTk0YzMzOThlZmE0ZWZmYWYzMTBiMjQwNzE0NzYxMTczOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"276326","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1261432733.SGD","BK4588","LU0321505439.SGD","LU1670711123.USD","CAR","LU2360032135.SGD","LU0882574055.USD","LU1989771016.USD","IE00BFTCPJ56.SGD","BK4230","IE00BJT1NW94.SGD","BK4585","LU0321505868.SGD","LU1430594728.SGD","LU1585245621.USD","LU2125154935.USD","LU0237698245.USD","LU1718418525.SGD","LU1032466523.USD","BK4022","BK4581","BK4534","LU1074936037.SGD","LU2125154778.USD","LU0114720955.EUR","BK4007","LU0061475181.USD","BMY","LU0456855351.SGD","BK4559","LU1291159041.SGD","BK4532","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU1670710661.SGD","LU1670711040.USD","LU2242646821.SGD","LU0868494617.USD","IE00BSNM7G36.USD","LU2133065610.SGD","LU1571399168.USD","LU1670710588.SGD","LU2242652126.USD","IE0009355771.USD"],"gpt_icon":0},{"id":"2439304600","title":"百时美施贵宝(中国)投资有限公司申请III类会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2439304600","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439304600?lang=zh_cn&edition=full","pubTime":"2024-05-31 07:15","pubTimestamp":1717110954,"startTime":"0","endTime":"0","summary":"金融界5月31日消息,据CDE官网沟通交流公示,于5月31日收到百时美施贵宝(中国)投资有限公司申请的“III类会议”,当前状态“处理中”。根据《药物研发与技术审评沟通交流管理办法》(2020年第48号通告),沟通交流会议分为Ⅰ类、Ⅱ类和Ⅲ类会议,就关键阶段重大问题进行沟通交流,Ⅲ类会议一般安排在申请后75日内召开。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405310715589f079334&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405310715589f079334&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0868494617.USD","BK4581","BK4585","LU1718418525.SGD","LU1670711123.USD","BK4532","IE0002141913.USD","IE00BSNM7G36.USD","LU0237698245.USD","LU1430594728.SGD","III","IE00BFTCPJ56.SGD","LU1670711040.USD","IE00B2B36J28.USD","LU2125154935.USD","IE00BJT1NW94.SGD","LU1291159041.SGD","LU1670710588.SGD","LU2125154778.USD","LU0321505868.SGD","LU1032466523.USD","LU1670710661.SGD","LU1585245621.USD","LU2242646821.SGD","LU2133065610.SGD","LU0061475181.USD","BK4534","LU0114720955.EUR","LU1989771016.USD","BK4588","LU1261432733.SGD","LU0882574055.USD","LU0321505439.SGD","IE0009355771.USD","BK4559","LU1074936037.SGD","LU1571399168.USD","BK4007","LU2242652126.USD","BMY","IE00BJJMRZ35.SGD","LU0456855351.SGD","LU2360032135.SGD","BK4134"],"gpt_icon":0},{"id":"2439673103","title":"百时美施贵宝表示其癌细胞疗法Breyanzi的批发标价为487,477.43美元——声明","url":"https://stock-news.laohu8.com/highlight/detail?id=2439673103","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439673103?lang=zh_cn&edition=full","pubTime":"2024-05-31 01:36","pubTimestamp":1717090564,"startTime":"0","endTime":"0","summary":"百时美施贵宝表示其癌细胞疗法Breyanzi的批发标价为487,477.43美元——声明","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405310136109f068686&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405310136109f068686&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1430594728.SGD","LU0321505439.SGD","LU1074936037.SGD","IE00B2B36J28.USD","LU2133065610.SGD","LU0321505868.SGD","BK4585","LU2242652126.USD","LU1670711123.USD","BK4581","IE0002141913.USD","LU2125154935.USD","LU1718418525.SGD","IE00BJJMRZ35.SGD","LU1261432733.SGD","IE00BJT1NW94.SGD","LU1670711040.USD","BK4559","BK4534","LU1032466523.USD","LU1571399168.USD","LU1291159041.SGD","LU1989771016.USD","LU0114720955.EUR","LU0061475181.USD","LU2242646821.SGD","LU2360032135.SGD","BK4588","LU1670710661.SGD","BK4532","IE0009355771.USD","LU0882574055.USD","LU1585245621.USD","LU0237698245.USD","LU1670710588.SGD","BK4007","BMY","LU2125154778.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU0456855351.SGD","IE00BSNM7G36.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bms.com","stockEarnings":[{"period":"1week","weight":-0.022},{"period":"1month","weight":0.0051},{"period":"3month","weight":-0.2169},{"period":"6month","weight":-0.2103},{"period":"1year","weight":-0.3542},{"period":"ytd","weight":-0.1951}],"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":0.0341},{"period":"3month","weight":0.0511},{"period":"6month","weight":0.1633},{"period":"1year","weight":0.2302},{"period":"ytd","weight":0.1473}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"百时美施贵宝公司于1933年8月根据特拉华州法律注册成立,名为百时美公司,继承了1887年在纽约成立的一家企业。1989年,由于合并,公司更名为百时美施贵宝公司。公司在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。他们在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。 他们预计他们对Celgene和MyoKardia的收购将进一步将他们定位为领先的生物制药公司,通过多项近期资产和额外的外部合作伙伴扩大他们的肿瘤学、血液学、免疫学和心血管产品组合。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.013265},{"month":2,"riseRate":0.545455,"avgChangeRate":0.009113},{"month":3,"riseRate":0.636364,"avgChangeRate":0.008429},{"month":4,"riseRate":0.488889,"avgChangeRate":-0.002113},{"month":5,"riseRate":0.577778,"avgChangeRate":0.003555},{"month":6,"riseRate":0.622222,"avgChangeRate":0.010543},{"month":7,"riseRate":0.4,"avgChangeRate":-0.003691},{"month":8,"riseRate":0.5,"avgChangeRate":-0.004242},{"month":9,"riseRate":0.522727,"avgChangeRate":0.010569},{"month":10,"riseRate":0.568182,"avgChangeRate":0.024004},{"month":11,"riseRate":0.613636,"avgChangeRate":0.020382},{"month":12,"riseRate":0.636364,"avgChangeRate":0.022108}],"exchange":"NYSE","name":"施贵宝","nameEN":"Bristol-Myers Squibb"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"施贵宝,BMY,施贵宝股票,施贵宝股票老虎,施贵宝股票老虎国际,施贵宝行情,施贵宝股票行情,施贵宝股价,施贵宝股市,施贵宝股票价格,施贵宝股票交易,施贵宝股票购买,施贵宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}